7-42932460-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031903.3(MRPL32):āc.74A>Gā(p.Glu25Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,460,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_031903.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPL32 | NM_031903.3 | c.74A>G | p.Glu25Gly | missense_variant | 1/3 | ENST00000223324.3 | NP_114109.1 | |
MRPL32 | NR_156497.1 | n.85A>G | non_coding_transcript_exon_variant | 1/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPL32 | ENST00000223324.3 | c.74A>G | p.Glu25Gly | missense_variant | 1/3 | 1 | NM_031903.3 | ENSP00000223324 | P1 | |
MRPL32 | ENST00000432845.1 | c.74A>G | p.Glu25Gly | missense_variant, NMD_transcript_variant | 1/3 | 2 | ENSP00000415581 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 249950Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135330
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460150Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 725978
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 22, 2024 | The c.74A>G (p.E25G) alteration is located in exon 1 (coding exon 1) of the MRPL32 gene. This alteration results from a A to G substitution at nucleotide position 74, causing the glutamic acid (E) at amino acid position 25 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at